FIGUR8

FIGUR8

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://figur8tech.com

Last Round

Series A

Extension

Aug 8, 2023

Total Funding Raised

$44.5M

Momentum Score

50 /100

Company Overview

FIGUR8, Inc. is an MIT spin-off company that has developed an FDA-registered, AI-powered wearable technology platform called the bioMotion Assessment Platform (bMAP). This system combines smart biosensors and intuitive software to provide objective, lab-grade data on musculoskeletal (MSK) health, including joint motion and muscle function. The platform is designed for use by healthcare providers, physical therapists, insurance companies, and employers to accurately diagnose injuries, guide treatment, monitor recovery, and manage risk. The company's mission is to standardize MSK health data, replacing subjective assessments with precise, actionable insights to improve patient outcomes and reduce healthcare costs.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Vertical SaaS, Medical Devices, InsurTech

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

musculoskeletal healthMSK healthwearable biosensorsbioMotion Assessment PlatformbMAPMSK techmovement healthAI-driven assessmentwearable techbiomechanics datamovement analyticsrecovery trackingphysical therapy techobjective MSK assessmentworkers' compensation techdigital health platformFDA-registered device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FIGUR8 Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

FIGUR8 Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionAug 8, 2023
Series AJun 23, 2021
SeedAug 27, 2019

Key People

Founding team and executive leadership

Steve DiPaola

Chief Operating Officer

Executive Team

FIGUR8 Investors

Notable investors and investment history

InvestorRounds
Phoenix Venture PartnersSeries A Extension, Series A
Taiwania CapitalSeries A
DigiTx PartnersSeries A Extension
Taiwan Global AngelsSeries A Extension
P5 Health VenturesSeries A, Seed
First Spark VenturesSeries A Extension
The E14 FundSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 9, 2025

    Launched Recovery Indicator for AI-driven musculoskeletal care.

  • Jan 10, 2025

    MovementMemo, a generative AI tool, officially launched on its bioMotion Assessment Platform.

FIGUR8 Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

FIGUR8 Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about FIGUR8's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range41
Year Founded2016
Last FundingAug 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.